Back

Watch Compare

MYRIAD GENETICS INC

Data quality: 100%

MYGN

Nasdaq Manufacturing Chemicals

$4.62

▼ $0.15 (-3.14%)

Mkt Cap: 432.01 M

Price

$4.62

Mkt Cap

432.01 M

Day Range

$4.56 — $4.74

52-Week Range

$3.76 — $8.59

Volume

601,083

Open $4.74

50D / 200D Avg

$4.90

5.66% below

50D / 200D Avg

$6.08

24.06% below

Quick Summary

Key Takeaways

Revenue grew 4.53% annually over 5 years — modest growth

Debt/Equity of 0.32 — conservative balance sheet

Generating 1.80 M in free cash flow

Revenue growth is decelerating — 1Y growth trails 5Y average by 6.09%

Growth

Revenue Growth (5Y)

4.53%

Above sector avg (1.82%)

Revenue (1Y)-1.56%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-96.18%

Below sector avg (-53.47%)

ROIC-57.85%

Net Margin-44.38%

Op. Margin-46.96%

Safety

Debt / Equity

0.32

Above sector avg (0.31)

Current Ratio2.33

Interest Coverage-36.88

Valuation

PE (TTM)

-1.18

Above sector avg (-1.47)

P/B Ratio1.16

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-1.2	-1.5
P/B	1.2	1.6
ROE %	-96.2	-53.5
Net Margin %	-44.4	-41.5
Rev Growth 5Y %	4.5	1.8
D/E	0.3	0.3

ETFs Holding This Stock

GSCTX GSCTX

0.34% weight

GTTRX GTTRX

0.34% weight

GSITX GSITX

0.34% weight

GTTTX GTTTX

0.34% weight

GTTUX GTTUX

0.34% weight

GSXPX GSXPX

0.34% weight

GSATX GSATX

0.34% weight

FSCC Federated Hermes MDT Small Cap Core ETF

0.30% weight

TASVX TASVX

0.20% weight

TSVRX TSVRX

0.20% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-1.56%	Revenue Growth (3Y)	4.63%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	4.53%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	824.50 M	Net Income (TTM)	-365.90 M
ROE	-96.18%	ROA	-52.07%
Gross Margin	69.93%	Operating Margin	-46.96%
Net Margin	-44.38%	Free Cash Flow (TTM)	1.80 M
ROIC	-57.85%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.32	Current Ratio	2.33
Interest Coverage	-36.88	Asset Turnover	1.17
Working Capital	196.80 M	Tangible Book Value	158.10 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-1.18	Forward P/E	N/A
P/B Ratio	1.16	P/S Ratio	0.52
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	0.42%
Market Cap	432.01 M	Enterprise Value	406.11 M
Per Share
EPS (Diluted TTM)	-3.95	Revenue / Share	8.82
FCF / Share	0.02	OCF / Share	0.02
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	-0.49%
SBC-Adj. FCF	-43.00 M	Growth Momentum	-6.09

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	824.50 M	837.60 M	753.20 M	678.40 M	690.60 M
Net Income	-365.90 M	-127.30 M	-263.30 M	-112.00 M	-27.20 M
EPS (Diluted)	-3.95	-1.41	-3.18	-1.39	-0.35
Gross Profit	576.60 M	585.40 M	—	—	—
Operating Income	-387.20 M	-123.50 M	-257.40 M	-140.60 M	-190.50 M
EBITDA	—	—	—	—	—
R&D Expenses	106.80 M	113.40 M	88.70 M	85.40 M	81.90 M
SG&A Expenses	—	—	572.90 M	514.70 M	537.80 M
D&A	53.70 M	61.20 M	61.90 M	52.70 M	62.80 M
Interest Expense	10.50 M	2.80 M	2.90 M	3.20 M	6.60 M
Income Tax	-29.20 M	3.80 M	1.10 M	-28.60 M	-29.90 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	706.60 M	1.03 B	1.15 B	1.20 B	1.32 B
Total Liabilities	338.60 M	326.50 M	363.30 M	312.90 M	352.90 M
Shareholders' Equity	368.00 M	701.10 M	783.20 M	885.80 M	967.80 M
Total Debt	119.90 M	39.60 M	38.50 M	0.0	0.0
Cash & Equivalents	149.60 M	102.40 M	132.10 M	56.90 M	258.40 M
Current Assets	332.60 M	298.00 M	313.60 M	274.60 M	484.80 M
Current Liabilities	133.80 M	164.10 M	155.90 M	137.20 M	204.30 M